Research Progress of Targeted Ultrasound Contrast Agent BR55 / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 118-122, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-927854
ABSTRACT
BR55 is an ultrasound contrast agent targeting vascular endothelial growth factor receptor 2,which can be used to detect tumor neovascularization and improve the diagnostic accuracy.Overseas researchers have used BR55 for human ultrasound molecular imaging,which showed good safety and tolerance.We reviewed the research progress on BR55 applied in the evaluation of tumor neovascularization from the composition,characteristics,animal experiments,and clinical studies of BR55.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Ultrasonography
/
Contrast Media
/
Vascular Endothelial Growth Factor Receptor-2
/
Microbubbles
/
Molecular Imaging
/
Neovascularization, Pathologic
Type of study:
Diagnostic study
Limits:
Animals
/
Humans
Language:
Chinese
Journal:
Acta Academiae Medicinae Sinicae
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS